<VariationArchive VariationID="48426" VariationName="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs)" VariationType="Duplication" Accession="VCV000048426" Version="13" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2015-01-30" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="57588" VariationID="48426">
      <GeneList>
        <Gene Symbol="USH2A" FullName="usherin" GeneID="7399" HGNC_ID="HGNC:12601" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q41</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="215622891" stop="216423448" display_start="215622891" display_stop="216423448" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="215796235" stop="216596737" display_start="215796235" display_stop="216596737" Strand="-" />
          </Location>
          <OMIM>608400</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_206933.4(USH2A):c.14031dup (p.Ala4678fs)</Name>
      <CanonicalSPDI>NC_000001.11:215671073:T:TT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1q41</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="215671073" stop="215671074" display_start="215671073" display_stop="215671074" variantLength="1" positionVCF="215671073" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="215844415" stop="215844416" display_start="215844415" display_stop="215844416" variantLength="1" positionVCF="215844415" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <OtherNameList>
        <Name>NM_206933.2:c.14031dupA</Name>
        <Name>p.Ala4678SerfsX5</Name>
      </OtherNameList>
      <ProteinChange>A4678fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.2" sequenceAccession="NM_206933" sequenceVersion="2" change="c.14031_14032insA">
            <Expression>NM_206933.2:c.14031_14032insA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.215844416dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.215844416dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.215671074dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.215671074dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009497.2" sequenceAccession="NG_009497" sequenceVersion="2" change="g.757375dup">
            <Expression>NG_009497.2:g.757375dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_206933.4" sequenceAccession="NM_206933" sequenceVersion="4" change="c.14031dup" MANESelect="true">
            <Expression>NM_206933.4:c.14031dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_996816.3" sequenceAccession="NP_996816" sequenceVersion="3" change="p.Ala4678fs">
            <Expression>NP_996816.3:p.Ala4678fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA262088" DB="ClinGen" />
        <XRef Type="rs" ID="397517988" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs) AND Rare genetic deafness" Accession="RCV000041749" Version="5">
        <ClassifiedConditionList TraitSetID="40993">
          <ClassifiedCondition DB="MedGen" ID="C5680250">Rare genetic deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2012-11-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs) AND not provided" Accession="RCV001380769" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs) AND multiple conditions" Accession="RCV002496661" Version="1">
        <ClassifiedConditionList TraitSetID="10164">
          <ClassifiedCondition DB="MedGen" ID="C3151138">Retinitis pigmentosa 39</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1848634">Usher syndrome type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs) AND Retinitis pigmentosa 39" Accession="RCV003450781" Version="1">
        <ClassifiedConditionList TraitSetID="595">
          <ClassifiedCondition DB="MedGen" ID="C3151138">Retinitis pigmentosa 39</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_206933.4(USH2A):c.14031dup (p.Ala4678fs) AND Usher syndrome type 2A" Accession="RCV003450780" Version="1">
        <ClassifiedConditionList TraitSetID="594">
          <ClassifiedCondition DB="MedGen" ID="C1848634">Usher syndrome type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-17" NumberOfSubmissions="5" NumberOfSubmitters="4" DateCreated="2015-01-30" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10729113</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">10909849</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20507924</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25211151</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25649381</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="10164" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="612971.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 2A</ElementValue>
                <XRef ID="MONDO:0010169" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH2A</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">USH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">US2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</Attribute>
                <XRef ID="NBK1341" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15241" />
                <XRef ID="15241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5440" />
                <XRef ID="5440" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301515</ID>
                <ID Source="BookShelf">NBK1341</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231178" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1848634" DB="MedGen" />
              <XRef ID="MONDO:0010169" DB="MONDO" />
              <XRef Type="MIM" ID="276901" DB="OMIM" />
            </Trait>
            <Trait ID="9776" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 39</ElementValue>
                <XRef ID="Retinitis+pigmentosa+39/9227" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013436" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP39</ElementValue>
                <XRef Type="MIM" ID="613809" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15715" />
                <XRef ID="15715" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151138" DB="MedGen" />
              <XRef ID="MONDO:0013436" DB="MONDO" />
              <XRef Type="MIM" ID="613809" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40993" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rare genetic deafness</ElementValue>
                <XRef ID="96210" DB="Orphanet" />
              </Name>
              <XRef ID="96210" DB="Orphanet" />
              <XRef ID="C5680250" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="595" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9776" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Retinitis pigmentosa 39</ElementValue>
                <XRef ID="Retinitis+pigmentosa+39/9227" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013436" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">RP39</ElementValue>
                <XRef Type="MIM" ID="613809" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15715" />
                <XRef ID="15715" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301590</ID>
                <ID Source="BookShelf">NBK1417</ID>
              </Citation>
              <XRef ID="791" DB="Orphanet" />
              <XRef ID="C3151138" DB="MedGen" />
              <XRef ID="MONDO:0013436" DB="MONDO" />
              <XRef Type="MIM" ID="613809" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="594" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6097" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">RETINAL DISEASE IN USHER SYNDROME TYPE IIA, MODIFIER OF</ElementValue>
                <XRef Type="Allelic variant" ID="612971.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">USHER SYNDROME, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608400.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Usher syndrome type 2A</ElementValue>
                <XRef ID="MONDO:0010169" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">USH2A</ElementValue>
                <XRef Type="MIM" ID="276901" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">USH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">US2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Usher syndrome type II (USH2) is characterized by the following: Congenital, bilateral sensorineural hearing loss that is mild to moderate in the low frequencies and severe to profound in the higher frequencies. Intact or variable vestibular responses. Retinitis pigmentosa (RP); progressive, bilateral, symmetric retinal degeneration that begins with night blindness and constricted visual fields (tunnel vision) and eventually includes decreased central visual acuity; the rate and degree of vision loss vary within and among families.</Attribute>
                <XRef ID="NBK1341" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15241" />
                <XRef ID="15241" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5440" />
                <XRef ID="5440" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301515</ID>
                <ID Source="BookShelf">NBK1341</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21697857</ID>
              </Citation>
              <XRef ID="231178" DB="Orphanet" />
              <XRef ID="886" DB="Orphanet" />
              <XRef ID="C1848634" DB="MedGen" />
              <XRef ID="MONDO:0010169" DB="MONDO" />
              <XRef Type="MIM" ID="276901" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="106645" SubmissionDate="2019-03-21" DateLastUpdated="2015-01-30" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="38036533|Orphanet:ORPHA96210" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000065445" DateUpdated="2015-01-30" DateCreated="2013-05-03" Type="SCV" Version="6" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-11-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The Ala4678fs variant in USH2A has not reported in the literature nor previously identified by our laboratory. This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at position 4678 and lead to a prematur e termination codon 5 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In summary, this variant meets our cri teria to be classified as pathogenic (http://pcpgm.partners.org/LMM).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_206933.2:EXON 64</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_206933.2:c.14031dupA</Name>
            <Name>p.Ala4678SerfsX5</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.215844415_215844416insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA96210" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348979</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5459813" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_206933.4:c.14031dup|OMIM:276901;613809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002810451" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.4:c.14031dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7822142" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_206933.4:c.14031dup|OMIM:276901" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004183107" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.4:c.14031dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="276901" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7822141" SubmissionDate="2023-12-17" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="NM_206933.4:c.14031dup|OMIM:613809" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004183106" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Genome-Nilou Lab" OrgID="507598" OrganizationCategory="laboratory" OrgAbbreviation="Genome Nilou" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>no</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_206933.4:c.14031dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613809" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14095489</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3104530" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4823857|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001578927" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10729113</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10909849</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20507924</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25649381</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25211151</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Ala4678Serfs*5) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 25211151). This variant is also known as c.14031_14032insA. ClinVar contains an entry for this variant (Variation ID: 48426). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="USH2A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.215844415_215844416insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5459813" TraitType="Disease" MappingType="XRef" MappingValue="613809" MappingRef="OMIM">
        <MedGen CUI="C3151138" Name="Retinitis pigmentosa 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3104530" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5459813" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="106645" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA96210" MappingRef="Orphanet">
        <MedGen CUI="C5680250" Name="Rare genetic deafness" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7822141" TraitType="Disease" MappingType="XRef" MappingValue="613809" MappingRef="OMIM">
        <MedGen CUI="C3151138" Name="Retinitis pigmentosa 39" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7822142" TraitType="Disease" MappingType="XRef" MappingValue="276901" MappingRef="OMIM">
        <MedGen CUI="C1848634" Name="Usher syndrome type 2A" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002020842</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

